Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Federal Trade Commission
Merck
Chubb
Argus Health
Queensland Health
Julphar
Teva
Accenture

Generated: May 23, 2018

DrugPatentWatch Database Preview

PYOPEN Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Pyopen patents expire, and when can generic versions of Pyopen launch?

Pyopen is a drug marketed by Glaxosmithkline and is included in one NDA.

The generic ingredient in PYOPEN is carbenicillin disodium. There are three drug master file entries for this compound. Additional details are available on the carbenicillin disodium profile page.
Summary for PYOPEN
Drug patent expirations by year for PYOPEN
Synonyms for PYOPEN
(2S,5R,6R)-6-(2-carboxy-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-6-[(2-carboxy-2-phenyl-acetyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-6-[(3-hydroxy-3-oxo-2-phenyl-propanoyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-6-[(3-hydroxy-3-oxo-2-phenylpropanoyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-6-{[carboxy(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
3523AH
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((carboxyphenylacetyl)amino)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta))-
4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[(2-carboxy-2-phenylacetyl)amino]-3,3-dimethyl-7-oxo-, (2S,5R,6R)-
4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[(carboxyphenylacetyl)amino]-3,3-dimethyl-7-oxo-, (2S,5R,6R)-
4697-36-3
4800-94-6 (di-hydrochloride salt)
6-(alpha-Carboxyphenylacetamido)penicillanic acid
6beta-(2-carboxy-2-phenylacetamido)-2,2-dimethylpenam-3alpha-carboxylic acid
AC1L2H29
AC1Q5QWI
AKOS030526150
alpha-Carboxybenzylpencillin
alpha-Carboxybenzylpenicillin solution
alpha-Phenyl(carboxymethylpenicillin)
AN-802
Anabactyl
API0004666
BSPBio_001931
C06869
C17H18N2O6S
Carbenicilina
Carbenicilina [INN-Spanish]
carbenicillin
Carbenicillin (INN)
Carbenicillin [INN:BAN]
CARBENICILLIN POTASSIUM
Carbenicillin, Ready Made Solution, 100 mg/mL in ethanol/water, 0.2 mum filtered
Carbenicillina
Carbenicillina [DCIT]
Carbenicilline
Carbenicilline [INN-French]
Carbenicillinum
Carbenicillinum [INN-Latin]
Carboxybenzyl Penicillin
Carboxybenzylpenicillin
Carboxybenzylpenicillin acid
CBPC
CHEBI:3393
CHEMBL1214
CS-2745
CTK1D5772
D02TBI
D07614
DB00578
DivK1c_000735
DTXSID6048464
EINECS 225-171-0
Epitope ID:116648
FPPNZSSZRUTDAP-UWFZAAFLSA-N
FT-0623457
Geopen
HSDB 3020
HY-B0525
IDI1_000735
KBio1_000735
KBio2_000518
KBio2_003086
KBio2_005654
KBio3_001151
KBioGR_000726
KBioSS_000518
Klebsiella Selective Supplement, for microbiology
LS-88731
Malonamic acid, N-(2-carboxy-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)hept-6-yl)-2-phenyl-
N-(2-carboxy-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)hept-6-yl)-2-phenylmalonamic acid
N-(2-Carboxy-3,3-dimethyl-7-oxo-4-thia-azabicyclo(3.2.0)hept-6-yl)-2-phenylmalonamic acid
NINDS_000735
NSC111071
SBI-0051303.P003
SC-18593
SCHEMBL3375
SPBio_000140
Spectrum_000098
Spectrum2_000120
Spectrum3_000326
Spectrum4_000263
Spectrum5_000900

US Patents and Regulatory Information for PYOPEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline PYOPEN carbenicillin disodium INJECTABLE;INJECTION 050298-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Glaxosmithkline PYOPEN carbenicillin disodium INJECTABLE;INJECTION 050298-006 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Glaxosmithkline PYOPEN carbenicillin disodium INJECTABLE;INJECTION 050298-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Glaxosmithkline PYOPEN carbenicillin disodium INJECTABLE;INJECTION 050298-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
US Department of Justice
Boehringer Ingelheim
Cerilliant
Farmers Insurance
Queensland Health
Healthtrust
Dow
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.